CN107445899A - 一种苯并咪唑类化合物及其制备方法 - Google Patents

一种苯并咪唑类化合物及其制备方法 Download PDF

Info

Publication number
CN107445899A
CN107445899A CN201710589775.0A CN201710589775A CN107445899A CN 107445899 A CN107445899 A CN 107445899A CN 201710589775 A CN201710589775 A CN 201710589775A CN 107445899 A CN107445899 A CN 107445899A
Authority
CN
China
Prior art keywords
compound
formula
preparation
reaction
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710589775.0A
Other languages
English (en)
Chinese (zh)
Inventor
刘雪静
韩迎
杨亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zaozhuang University
Original Assignee
Zaozhuang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zaozhuang University filed Critical Zaozhuang University
Priority to CN201710589775.0A priority Critical patent/CN107445899A/zh
Priority to US16/485,457 priority patent/US10787420B2/en
Priority to PCT/CN2017/103942 priority patent/WO2019015112A1/zh
Priority to JP2020509138A priority patent/JP6944682B2/ja
Publication of CN107445899A publication Critical patent/CN107445899A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN201710589775.0A 2017-07-19 2017-07-19 一种苯并咪唑类化合物及其制备方法 Pending CN107445899A (zh)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN201710589775.0A CN107445899A (zh) 2017-07-19 2017-07-19 一种苯并咪唑类化合物及其制备方法
US16/485,457 US10787420B2 (en) 2017-07-19 2017-09-28 Benzimidazole compound and preparation method thereof
PCT/CN2017/103942 WO2019015112A1 (zh) 2017-07-19 2017-09-28 一种苯并咪唑类化合物及其制备方法
JP2020509138A JP6944682B2 (ja) 2017-07-19 2017-09-28 ベンゾイミダゾール系化合物の製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710589775.0A CN107445899A (zh) 2017-07-19 2017-07-19 一种苯并咪唑类化合物及其制备方法

Publications (1)

Publication Number Publication Date
CN107445899A true CN107445899A (zh) 2017-12-08

Family

ID=60487826

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710589775.0A Pending CN107445899A (zh) 2017-07-19 2017-07-19 一种苯并咪唑类化合物及其制备方法

Country Status (4)

Country Link
US (1) US10787420B2 (cg-RX-API-DMAC7.html)
JP (1) JP6944682B2 (cg-RX-API-DMAC7.html)
CN (1) CN107445899A (cg-RX-API-DMAC7.html)
WO (1) WO2019015112A1 (cg-RX-API-DMAC7.html)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108640876A (zh) * 2018-08-02 2018-10-12 华侨大学 一种多取代苯并咪唑衍生物及其制备方法
CN108863820A (zh) * 2018-07-30 2018-11-23 枣庄学院 一种取代邻苯二胺的合成方法
CN109020895A (zh) * 2018-08-07 2018-12-18 枣庄学院 一种金属催化的1-苄胺基取代苯并咪唑的合成方法
CN110256359A (zh) * 2019-06-20 2019-09-20 武汉工程大学 2-氨基苯并咪唑衍生物及其合成和应用
CN110759903A (zh) * 2018-07-26 2020-02-07 南开大学 一种噻苯唑的合成新方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106866545A (zh) * 2017-03-31 2017-06-20 刘雪静 1‑环烷烃‑5‑硝基‑1h‑苯并[d]咪唑类化合物及其制备方法
CN106946862A (zh) * 2017-03-31 2017-07-14 刘雪静 1‑烷烃‑6‑甲基‑5‑硝基‑1h‑苯并[d]咪唑类化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576077A (en) * 1977-04-13 1980-10-01 Roussel Lab Ltd 4,5-dihydro-4-oxophyrrolo(1,2-)-quinoxaline-2-carboxylic acids and derivatives
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US20060194871A1 (en) * 2003-04-11 2006-08-31 Barvian Kevin K Heterocyclic mchr1 antagoists
WO2008134354A1 (en) * 2007-04-27 2008-11-06 Array Biopharma, Inc. TNF-α PRODUCTION INHIBITOR
JP5944823B2 (ja) * 2010-07-02 2016-07-05 あすか製薬株式会社 複素環化合物及びp27Kip1分解阻害剤
WO2015171951A1 (en) * 2014-05-07 2015-11-12 The Regents Of The University Of Colorado, A Body Corporate 2-(4-aryl-1h-imidazol-1-yl)aniline compounds
MA40957A (fr) * 2014-10-09 2017-09-19 Biomarin Pharm Inc Inhibiteurs de biosynthèse d'héparane sulfate pour traiter des maladies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106866545A (zh) * 2017-03-31 2017-06-20 刘雪静 1‑环烷烃‑5‑硝基‑1h‑苯并[d]咪唑类化合物及其制备方法
CN106946862A (zh) * 2017-03-31 2017-07-14 刘雪静 1‑烷烃‑6‑甲基‑5‑硝基‑1h‑苯并[d]咪唑类化合物及其制备方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KARL J. OKOLOTOWICZ ET AL.: "1,5-Disubstituted benzimidazoles that direct cardiomyocyte differentiation from mouse embryonic stem cells", 《BIOORGANIC & MEDICINAL CHEMISTRY》 *
王晶.: "基于原位生成的C=N双键的串联反应研究", 《中国博士学位论文全文数据库·工程科技I辑》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110759903A (zh) * 2018-07-26 2020-02-07 南开大学 一种噻苯唑的合成新方法
CN110759903B (zh) * 2018-07-26 2022-10-28 南开大学 一种噻苯唑的合成新方法
CN108863820A (zh) * 2018-07-30 2018-11-23 枣庄学院 一种取代邻苯二胺的合成方法
CN108640876A (zh) * 2018-08-02 2018-10-12 华侨大学 一种多取代苯并咪唑衍生物及其制备方法
CN109020895A (zh) * 2018-08-07 2018-12-18 枣庄学院 一种金属催化的1-苄胺基取代苯并咪唑的合成方法
CN110256359A (zh) * 2019-06-20 2019-09-20 武汉工程大学 2-氨基苯并咪唑衍生物及其合成和应用

Also Published As

Publication number Publication date
US20200002291A1 (en) 2020-01-02
JP6944682B2 (ja) 2021-10-06
JP2020518661A (ja) 2020-06-25
US10787420B2 (en) 2020-09-29
WO2019015112A1 (zh) 2019-01-24

Similar Documents

Publication Publication Date Title
CN110719902B (zh) Ssao抑制剂
CN1315809C (zh) 喹啉衍生物和其作为5-ht6配体的用途
US5298657A (en) Preparation of substituted guanidines
JP6944682B2 (ja) ベンゾイミダゾール系化合物の製造方法
EP3215507B1 (en) Synthesis of copanlisib and its dihydrochloride salt
JP2020518661A5 (cg-RX-API-DMAC7.html)
JP2007505075A (ja) キノリン化合物およびそれを含む医薬組成物
CN108947890B (zh) 一种制备二取代4-氨基咔唑类化合物的方法
CN111285847A (zh) 制备艾乐替尼的方法
CN110092760B (zh) 一种3-氟代烷氧基-2(1h)-喹喔啉酮及其合成方法
CN115197261B (zh) 噁二氮杂硼衍生物的合成方法
CN113336703B (zh) 1,3,4,5-四取代1h-吡唑衍生物的合成
CN105001163B (zh) 一种四取代咪唑的合成方法
CN110790713B (zh) 用于合成2-羟基喹喔啉的区域选择性一步方法
CN103193715A (zh) 一种5,6-二氢嘧啶酮衍生物的制备方法
AU2004203941B2 (en) Process for preparing substituted imidazole derivatives and intermediates used in the process
CN111533706A (zh) 一种1,4,6-三取代1,2-二氢-三嗪类化合物的制备方法
JPH06184074A (ja) 1−アルコキシナフタレン−2−カルボキサミド誘導体、その製法並びに該誘導体を含有する医薬組成物
CN107382769B (zh) 一种1-芳基-3-叠氮基-4,4,4-三氟-1-丁烯化合物的制备方法
JP2020535192A (ja) レナリドミドの結晶形
CN115960047B (zh) 一种3-苯基-1h-吡唑类化合物及其用途
CN101665508A (zh) 4位-1H-1,2,3-三唑-β-内酰胺衍生物的制备方法
CN110759923B (zh) 嘧啶并吡咯并哒嗪衍生物、其中间体、制备方法、药物组合物和用途
KR20240038024A (ko) B형 간염 바이러스 뉴클레오캡시드 억제제의 제조 방법
CN108863820B (zh) 一种取代邻苯二胺的合成方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20171208

RJ01 Rejection of invention patent application after publication